Neurocrine Biosciences
Get Full AccessDescription
- Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Â Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
-
Headquarters:12780 El Camino Real , San Diego, California, United States
More -
Phone Number: +1 858-617-7600
-
Website: https://www.neurocrine.com
-
Employees:807
-
Revenue:> $1B
-
Legal Name:Neurocrine Biosciences
-
Neurocrine Biosciences's Social Media
-
Is this data correct?
-
| NAICS Code: 621111 |
NYSE: NBIX
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Neurocrine Biosciences
-
Where are Neurocrine Biosciences's Headquarters?
Neurocrine Biosciences's Headquarters are in 12780 El Camino Real ,San Diego,California,United States
-
What is Neurocrine Biosciences's phone number?
Neurocrine Biosciences's phone number is +1 858-617-7600
-
What is Neurocrine Biosciences's stock symbol?
Neurocrine Biosciences's stock symbol is NBIX
-
What is Neurocrine Biosciences's official website?
Neurocrine Biosciences's official website is https://www.neurocrine.com
-
What is Neurocrine Biosciences's Revenue?
Neurocrine Biosciences's revenue is > $1B
-
What is Neurocrine Biosciences's NAICS code?
Neurocrine Biosciences's NAICS code is 621111
-
How many employees are working in Neurocrine Biosciences
Neurocrine Biosciences has 807 employees
-
What is Neurocrine Biosciences's Industry?
Neurocrine Biosciences is in the industry of Biotechnology